CIK 0001119774
- Accelerated filer
COMPUGEN LTD
Sign in to watch- Ticker
- CGEN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Other
- Phone
- +972 37658585
- Business address
- 26 HAROKMIM STREET, BUILDING D, HOLON, Israel, 5885849
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-29 | Levine Zurit SVP, Business Development | Grant or award | +18,000 | 47,375 | ||
| 2026-07-29 | Levine Zurit SVP, Business Development | Grant or award · Share Option (right to buy) | +24,000 | 24,000 | ||
| 2026-07-09 | Levine Zurit SVP, Business Development | Exercise or conversion 10b5-1 | +1,875 | $0.83 | $2K | 31,250 |
| 2026-07-09 | Levine Zurit SVP, Business Development | Sale 10b5-1 | −1,875 | $2.50 | $5K | 29,375 |
| 2026-07-09 | Levine Zurit SVP, Business Development | Exercise or conversion · Share Option (right to buy) 10b5-1 | −1,875 | 3,750 | ||
| 2026-04-24 | Levine Zurit SVP, Business Development | Exercise or conversion 10b5-1 | +2,000 | $1.15 | $2K | 31,375 |
| 2026-04-24 | Levine Zurit SVP, Business Development | Sale 10b5-1 | −2,000 | $3.20 | $6K | 29,375 |
| 2026-04-24 | Levine Zurit SVP, Business Development | Exercise or conversion · Share Option (right to buy) 10b5-1 | −2,000 | 52,000 | ||
| 2026-04-14 | Levine Zurit SVP, Business Development | Exercise or conversion 10b5-1 | +2,000 | $1.15 | $2K | 31,375 |
| 2026-04-14 | Levine Zurit SVP, Business Development | Sale 10b5-1 | −2,000 | $2.80 | $6K | 29,375 |
| 2026-04-14 | Levine Zurit SVP, Business Development | Exercise or conversion · Share Option (right to buy) 10b5-1 | −2,000 | 54,000 | ||
| 2026-04-10 | Levine Zurit SVP, Business Development | Exercise or conversion 10b5-1 | +1,125 | $0.83 | $933 | 30,500 |
| 2026-04-10 | Levine Zurit SVP, Business Development | Exercise or conversion 10b5-1 | +2,000 | $1.15 | $2K | 32,500 |
| 2026-04-10 | Levine Zurit SVP, Business Development | Sale 10b5-1 | −3,125 | $2.56 | $8K | 29,375 |
| 2026-04-10 | Levine Zurit SVP, Business Development | Exercise or conversion · Share Option (right to buy) 10b5-1 | −1,125 | 5,625 | ||
| 2026-04-10 | Levine Zurit SVP, Business Development | Exercise or conversion · Share Option (right to buy) 10b5-1 | −2,000 | 56,000 | ||
| 2026-04-10 | Levine Zurit SVP, Business Development | Exercise or conversion 10b5-1 | +1,125 | $0.83 | $933 | 30,500 |
| 2026-04-10 | Levine Zurit SVP, Business Development | Exercise or conversion 10b5-1 | +2,000 | $1.15 | $2K | 32,500 |
| 2026-04-10 | Levine Zurit SVP, Business Development | Sale 10b5-1 | −3,125 | $2.56 | $8K | 29,375 |
| 2026-04-10 | Levine Zurit SVP, Business Development | Exercise or conversion · Share Option (right to buy) 10b5-1 | −1,125 | 5,625 |
Page 1 of 2 · 37 trades